Wigge acted as legal advisor to Vimab Group in connection with the sale of its wholly owned subsidiary Vimab to Grimaldi Industri. The purchase price amounted to SEK 140 million on a cash and debt free basis.
Vimab is a leading provider of valve services with nationwide operations and a strong presence in sectors including the nuclear and process industries. The divestment forms part of Vimab Group’s strategic shift towards energy storage.
Vimab Group’s shares are admitted to trading on Nasdaq First North Growth Market.
